UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000047592
Receipt No. R000054273
Scientific Title Osaka Medical and Pharmaceutical University-Heart Failure Registry:OMPU-HF Registry
Date of disclosure of the study information 2022/05/01
Last modified on 2022/04/26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Osaka Medical and Pharmaceutical University-Heart Failure Registry:OMPU-HF Registry
Acronym Osaka Medical and Pharmaceutical University-Heart Failure Registry:OMPU-HF Registry
Scientific Title Osaka Medical and Pharmaceutical University-Heart Failure Registry:OMPU-HF Registry
Scientific Title:Acronym Osaka Medical and Pharmaceutical University-Heart Failure Registry:OMPU-HF Registry
Region
Japan

Condition
Condition Heart Failure
Classification by specialty
Medicine in general Cardiology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To investigate the prognostic factor in patients with hospitalized heart failure
Basic objectives2 Others
Basic objectives -Others To investigate the prognostic factor in patients with hospitalized heart failure
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes 1) all-cause death
2) cardiovascular death
3) heart failure rehospitalization
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit
100 years-old >=
Gender Male and Female
Key inclusion criteria Hospitalized heart failure patients
Key exclusion criteria prior history of heart transplantation
patients who are judged by the investigator to be inappropriate as research subjects
Target sample size 2000

Research contact person
Name of lead principal investigator
1st name Kazushi
Middle name
Last name Sakane
Organization Osaka Medical and Pharmaceutical University
Division name Department of Cardiology
Zip code 569-8686
Address 2-7, daigaku-machi, takatsuki city, Osaka
TEL 0726831221
Email kazushi.sakane@ompu.ac.jp

Public contact
Name of contact person
1st name Kazushi
Middle name
Last name Sakane
Organization Osaka Medical and Pharmaceutical University
Division name Department of Cardiology
Zip code 569-8686
Address 2-7, daigaku-machi, takatsuki city, Osaka
TEL 0726831221
Homepage URL
Email kazushi.sakane@ompu.ac.jp

Sponsor
Institute Osaka Medical and Pharmaceutical University
Institute
Department

Funding Source
Organization Osaka Medical and Pharmaceutical University
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Osaka Medical and Pharmaceutical University
Address 2-7, daigaku-machi, takatsuki city, Osaka
Tel 0726831221
Email kazushi.sakane@ompu.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2022 Year 05 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2014 Year 04 Month 01 Day
Date of IRB
Anticipated trial start date
2014 Year 04 Month 01 Day
Last follow-up date
2022 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information Non-interventional observational study without randomization

Management information
Registered date
2022 Year 04 Month 26 Day
Last modified on
2022 Year 04 Month 26 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054273

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.